Vascular liver disorders (II): Portal vein thrombosis

Netherlands Journal of Medicine

Volumn 67, Issue 2, 2009, Pages 46-53

  Hoekstra, J ^a   Janssen, H L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anticoagulation; Myeloproliferative disorder; Portal hypertension; Portal vein; Thrombosis

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; JANUS KINASE 2; VASOCONSTRICTOR AGENT;

ABDOMINAL PAIN; ANTICOAGULANT THERAPY; BLOOD TRANSFUSION; BLOODY DIARRHEA; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL VARICES BLEEDING; HEPATOBILIARY SYSTEM CANCER; HUMAN; INTESTINE INFARCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MYELOPROLIFERATIVE DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PORTAL HYPERTENSION; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; PROGNOSIS; RECANALIZATION; REVIEW; SPLENOMEGALY; SURGICAL THROMBECTOMY; SURVIVAL RATE; THROMBOPHILIA; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ANTICOAGULANTS; CHRONIC DISEASE; HUMANS; HYPERTENSION, PORTAL; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 60849132746     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Cohen J, Edelman RR, Chopra S. Portal vein thrombosis: A review. Am J Med. 1992;92:173-82.
2. Janssen HL, Meinardi JR, Vleggaar FP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deliciencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study. Blood. 2000;96:2364-8.
3. Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34.
4. Valla DC, Condat B. Portal vein thrombosis in adults: Pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865-71.
5. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet. 1999;353:1167-73.
6. Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Castroenterol. 2006;12:2115-9.
7. Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Clin Pract Gastroenterol Hepatol. 2006;3:505-15.
8. Primignani M, Martinelli I, Bucciarelli P, et al. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology. 2005;41:603-8.
9. Valla D, Casadevall N, Huisse MG, et al. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology. 1988;94:1063-9.
10. Janssen HL, Wijnhoud A, Haagsma EB, et al. Extrahepatic portal vein thrombosis: Aetiology and determinants of survival. Gut. 2001;49:720-4.
11. Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children. I. Clinical Investigation and hemorrhage risk. J Pediatr. 1983;103:696-702.
12. Morag I, Epelman M, Daneman A, et al. Portal vein thrombosis in the neonate: Risk factors, course, and outcome. J Pediatr. 2006;148:735-9.
13. Belli L, Romani F, Sansalone CV, Aseni P, Rondinara G. Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg. 1986;203:286-91.
14. Monarca A, Natangelo R, Tavani E, Azzolini V. Cirrhosis and portal vein thrombosis. Gastroenterology. 1986;90:509.
15. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992;16:1195-8.
16. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736-41.
17. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28:751-5.
18. Pirisi M, Avellini C, Fabris C, et al. Portal vein thrombosis in hepatocellular carcinoma: Age and sex distribution in an autopsy study. J Cancer Res Clin Oncol. 1998;124:397-400.
19. Rabe C, Pilz T, Klostermann C, et al. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol. 2001;7:208-15.
20. Bernades P, Baetz A, Levy P, Belghiti J, Menu Y, Fekete F. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci. 1992;37:340-6.
21. Winslow ER, Brunt LM, Drebin JA, Soper NJ, Klingensmith ME. Portal vein thrombosis after splenectomy. Am J Surg. 2002;184:631-5; discussion 5-6.
22. De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost. 1997;23:411-8.
23. Kiladjian JJ, Cervantes F, Leebeek FWG, et al. Role of JAK 2 mutation detection in budd-chiari syndrome (BCS) and portal vein thrombosis (PVT) associated to MPD. Blood. 2006;108:116a-a.
24. Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors. Hepatology. 2000;31:587-91.
25. Erkan O, Bozdayi AM, Disibeyaz S, et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol. 2005;17:339-43.
26. Amitrano L, Brancaccio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31:345-8.
27. Amitrano L, Brancaccio V, Cuardascione MA, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: Role of genetic thrombophilia. Endoscopy. 2002;34:535-8.
28. Connolly GC, Chen R, Hyrien O, et al. Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res. 2008;122(3):299-306. Epub 2007 Nov 28.
29. Ogren M, Bergqvist D, Bjorck M, Acosta S, Sternby NH. High incidence of concomitant venous thromboembolism in patients with portal vein thrombosis: A population study based on 23 796 consecutive autopsies. J Thromb Haemost. 2007;5:198-200.
30. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32:466-70.
31. Shah TU, Semelka RC, Voultsinos V, et al. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl. 2006;12:1682-8.
32. Tessler FN, Gehring BJ, Gomes AS, et al. Diagnosis of portal vein thrombosis: Value of color Doppler imaging. AJR Am J Roentgenol. 1991;157:293-6.
33. Kuszyk BS, Osterman FA, Jr., Venbrux AC, et al. Portal venous system thrombosis: Helical CT angiography before transjugular intrahepatic portosystemic shunt creation. Radiology. 1998;206:179-86.
34. Kumar S, Sarr MC, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345:1683-8.
35. Plessier A, Murad SD, Hernandez-Guerra M, et al. A prospective multicentric follow-up study on 105 patients with acute portal vein thrombosis (PVT): Results from the european network for vascular disorders of the liver (en-vie). Hepatology. 2007;46:310a-a.
36. Fisher NC, Wilde JT, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? Gut. 2000;46:534-9.
37. McNamara C, Juneja S, Wolf M, Grigg A. Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts. Clin Lab Haematol. 2002;24:239-42.
38. Chait Y, Condat B, Cazals-Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 2005;129:553-60.
39. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779-90.
40. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-61.
41. Colaizzo D, Amitrano L, Tiscia GL, et al. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost. 2007;5:55-61.
42. De Stefano V, Fiorini A, Rossi E, et al. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost. 2007;5:708-14.
43. Primignani M, Barosi G, Bergamaschi G, et al. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology. 2006;44:1528-34.
44. Ohnishi K, Okuda K, Ohtsuki T, et al. Formation of hilar collaterals or cavernous transformation after portal vein obstruction by hepatocellular carcinoma. Observations in tan patients. Gastroenterology. 1984;87:1150-3.
45. Lebrec D, Bataille C, Bercoff E, Valla D. Hemodynamic changes in patients with portal venous obstruction. Hepatology. 1983;3:550-3.
46. De Gaetano AM, Lafortune M, Patriquin H, De Franco A, Aubin B, Paradis K. Cavernous transformation of the portal vein: Patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR Am J Roentgenol. 1995;165:1151-5.
47. Ueno N, Sasaki A, Tomiyama T, Tano S, Kimura K. Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein. J Clin Ultrasound. 1997;25:227-33.
48. Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:2464-70.
49. Condat B, Pessione F, Hillaire S, et al. Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490-7.
50. Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol. 2001;16:1086-92.
51. Condat B, Vilgrain V, Asselah T, et al. Portal cavernoma-associated choiangiopathy: A clinical and MR choiangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302-8.
52. Khuroo MS, Yattoo GN, Zargar SA, et al. Biliary abnormalities associated with extrahepatic portal venous obstruction. Hepatology. 1993;17:807-13.
53. Malkan GH, Bhatia SJ, Bashir K, et al. Cholangiopathy associated with portal hypertension: Diagnostic evaluation and clinical implications. Gastrointest Endosc. 1999;49:344-8.
54. Nagi B, Kochhar R, Bhasin D, Singh K. Cholangiopathy in extrahepatic portal venous obstruction. Radiological appearances. Acta Radiol. 2000;41:612-5.
55. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167-76.
56. Aytekin C, Boyvat F, Kurt A, Yologlu Z, Coskun M. Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol. 2001;39:80-2.
57. Ozkan U, Oguzkurt L, Tercan F, Tokmak N. Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis. Diagn Interv Radiol. 2006;12:105-7.
58. Rossi C, Zambruni A, Ansaloni F, et al. Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. Transplantation. 2004;78:938-40.
59. Uflacker R, Alves MA, Cantisani GG, Souza HP, Wagner J, Moraes LF. Treatment of portal vein obstruction by percutaneous transhepatic angioplasty. Gastroenterology. 1985;88:176-80.
60. Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:651-61.
61. Bilbao JI, Vivas I, Elduayen B, Alonso C, et al. Limitations of percutaneous techniques in the treatment of portal vein thrombosis. Cardiovasc Intervent Radiol. 1999;22:417-22.
62. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-38.
63. Schepke M, Kleber G, Nurnberg D, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2004;40:65-72.
64. Lo GM, Lai KH, Cheng JS, Chen MM, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33:1060-4.
65. Banares R, Albillos A, Rincon D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: A meta-analysis. Hepatology. 2002;35:609-15.
66. Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenteroiogy. 2002;123:1013-9.
67. de la Pena J, Brullet E, Sanchez-Hernandez E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: A multicenter trial. Hepatology. 2005;41:572-8.
68. Yachha SK, Sharma BC, Kumar M, Khanduri A. Endoscopic sclerotherapy for esophageal varices in children with extrahepatic portal venous obstruction: A follow-up study. J Pediatr Gastroenterol Nutr. 1997;24:49-52.
69. Vleggaar FP, van Buuren HR, Schalm SW. Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population. Eur J Gastroenterol Hepatol. 1998;10:81-5.
70. Spaander V, Murad SD, van Buuren H, Hansen B, Kuipers E, Janssen H. Endoscopic treatment of esophagogastric variceal bleeding in patients with non-cirrhotic extrahepatic portal vein thrombosis: A long-term cohort study. Gastroenterology. 2006;130:A669-70.
71. Lopes CV, Pereira-Lima JC, Pereira-Lima LF, et al. The efficacy of endoscopic ligation for the prevention of variceal rebleeding in cirrhotic patients according to the hepatocellular function. Hepatogastroenterology. 2004;51:195-200.
72. Orloff MJ, Orloff MS, Girard B, Orloff SL. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. J Am Coll Surg. 2002;194:717-28; discussion 28-30.
73. Warren WD, Henderson JM, Millikan WJ, Calambos JT, Bryan FC. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis. Ann Surg. 1988;207:623-34.
74. Blum U, Haag K, Rossle M, et al. Noncavernomatous portal vein thrombosis in hepatic cirrhosis: Treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology. 1995;195:153-7.
75. Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23:767-75.
76. Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol. 2006;29:785-90.
77. Sezgin O, Oguz D, Altintas E, Saritas U, Sahin B. Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein. Gastrointest Endosc. 2003;58:602-8.
78. Dumortier J, Vaillant E, Boillot O, et al. Diagnosis and treatment of biliary obstruction caused by portal cavernoma. Endoscopy. 2003;35:446-50.
79. Chaudhary A, Dhar P, Sarin SK, et al. Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: Surgical management. Br J Surg. 1998;85:326-9.
80. Khare R, Sikora SS, Srikanth G, et al. Extrahepatic portal venous obstruction and obstructive jaundice: Approach to management. J Gastroenterol Hepatol. 2005;20:56-61.
81. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: Usefulness of screening and anticoagulation. Gut. 2005;54:691-7.
82. Llado L, Fabregat J, Castellote J, et al. Management of portal vein thrombosis in liver transplantation: Influence on morbidity and mortality. Clin Transplant. 2007;21:716-21.
83. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: Risk factors, screening, management, and outcome. Transplantation. 2000;69:1873-81.
84. Webb LJ, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med. 1979;48:627-39.